And logically in a higher inflation fuller employment environment big pharma is going to do very well. And that means lots of money for acquisitions and deals.
Millions of people are still moving into the affluent classes in China and India every year. And we have some good things going on the Chinese side.
Just got to ignore the noise until mid next year and then hang on during the run up to results in Q1 2023. There’ll be plenty of tree shakes and games over that period.
Ann: Immutep Capital Raising Presentation, page-161
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $566.5M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.5¢ | 38.5¢ | $997.5K | 2.559M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 85852 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 75389 | 4 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |